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ABSTRACT
 
Objective:
 
A large number of possible techniques are avail-
able when conducting matching procedures, yet coherent
guidelines for selecting the most appropriate application do
not yet exist. In this article we evaluate several matching
techniques and provide a suggested guideline for selecting the
best technique.
 
Methods:
 
The main purpose of a matching procedure is to
reduce selection bias by increasing the balance between the
treatment and control groups. The following approach, con-
sisting of ﬁve quantiﬁable steps, is proposed to check for bal-
ance: 1) Using two sample 
 
t
 
-statistics to compare the means
of the treatment and control groups for each explanatory
variable; 2) Comparing the mean difference as a percentage
of the average standard deviations; 3) Comparing percent
reduction of bias in the means of the explanatory variables
before and after matching; 4) Comparing treatment and con-
trol density estimates for the explanatory variables; and 5)
Comparing the density estimates of the propensity scores of
the control units with those of the treated units. We investi-
gated seven different matching techniques and how they per-
formed with regard to proposed ﬁve steps. Moreover, we
estimate the average treatment effect with multivariate anal-
ysis and compared the results with the estimates of propen-
sity score matching techniques. The Medstat MarketScan
Data Base provided data for use in empirical examples of the
utility of several matching methods. We conducted nearest
neighborhood matching (NNM) analyses in seven ways:
replacement, 2 to 1 matching, Mahalanobis matching (MM),
MM with caliper, kernel matching, radius matching, and the
stratiﬁcation method.
 
Results:
 
Comparing techniques according to the above cri-
teria revealed that the choice of matching has signiﬁcant
effects on outcomes. Patients with asthma are compared with
patients without asthma and cost of illness ranged from
$2040 to $4463 depending on the type of matching. After
matching, we looked at the insigniﬁcant differences or larger
 
P
 
-values in the mean values (criterion 1); low mean differ-
ences as a percentage of the average standard deviation (cri-
terion 2); 100% reduction bias in the means of explanatory
variables (criterion 3); and insigniﬁcant differences when
comparing the density estimates of the treatment and control
groups (criterion 4 and criterion 5). Mahalanobis matching
with caliber yielded the better results according all ﬁve cri-
teria (Mean 
 
=
 
 $4463, SD 
 
=
 
 $3252). We also applied multi-
variate analysis over the matched sample. This decreased the
deviation in cost of illness estimates more than threefold
(Mean 
 
=
 
 $4456, SD 
 
=
 
 $996).
 
Conclusion:
 
Sensitivity analysis of the matching techniques
is especially important because none of the proposed meth-
ods in the literature is a priori superior to the others. The sug-
gested joint consideration of propensity score matching and
multivariate analysis offers an approach to assessing the
robustness of the estimates.
 
Keywords:
 
 propensity score matching, randomization, selec-
tion bias.
 
Introduction
 
A key problem that often plagues observational studies
is the lack of randomization in assigning individuals to
either treatment or control groups. Because of this, the
estimation of the effects of treatment may be biased by
the existence of confounding factors.
Randomized control trials (RCTs) are viewed as the
ideal evaluation technique for estimating treatment
effects, because when randomization works, measura-
ble and unmeasurable differences between treatment
and control groups are minimized or avoided entirely,
leaving only one variable (i.e., assignment to treatment
or control group status) as the only remaining, likely
cause for differences in observed outcomes. Often,
however, randomization is not feasible or permissible
 
.
 
Rossi and Freeman [1] noted that randomization is
difﬁcult to apply or maintain when: 1) The treatment is
in its early stages. Projects in early stages may need fre-
quent changes in structure to perfect their operation
and delivery; 2) the enrollment demand is minimal.
When very few patients express in the treatment, diver-
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sion of a subset of these potential patients to control
status may be unacceptable; 3) patients have ethical
qualms about denying treatment to those perceived to
be in need; 4) time and money are limited. RCTs often
require extensive management process that tend to
consume large amount of time and money; 5) RCT is
likely to be less generalizable to the population of
interest; and 6) the integrity of the evaluation may be
threatened easily. This may occur by failure of treat-
ment or control group members to follow protocols,
morbidity or mortality, or other reasons for dropping
out of the evaluation [2].
Under these circumstances, observational studies
would often be the design of choice if the investigator
could adjust for the large confounding biases. Propen-
sity score matching techniques have been devised for
this purpose [3]. Formally, propensity score for a
patient is the probability of being treated conditional
on the patients’ covariates values such as demographic
and clinical factors. If we have two patients, one in the
treatment and one in the control group, with the same
or a similar propensity score, we can consider these
subjects randomly assigned to each group and thus as
equivalently treated or not treated.
Unlike RCT with its long and well-documented his-
tory, the application of design processes in propensity
score matching are not well established. Moreover,
there are numerous factors to consider in implement-
ing propensity score matching in general, a process fur-
ther complicated by the number of matching routines
available. Despite its frequent use in observational
research, no coherent, rule-based decision matrix cur-
rently exists in the literature. The potential for misap-
plication of these techniques is high and contributes to
the controversy as to the value of methodology itself.
In this article, we looked at seven different types of
matching techniques and propose ﬁve quantiﬁable cri-
teria to help health service researchers choose the best
matching techniques for their data sets. We will brieﬂy
describes the problem of evaluation and then demon-
strate why we believe propensity score matching offers
a solution. We will summarize the seven different types
of matching techniques with proposed tests demon-
strate the application of these guidelines to the Med-
stat MarketScan Data (Thomson-Medstat, Ann Arbor,
MI) and ﬁnally focus on a discussion of pertinent issue
and ends with concluding thoughts.
 
Evaluation Problem and Propensity 
Score Matching
 
Empirical methods in health economics have been
developed to answer counterfactual questions [4–8]
such as, “What would have happened to a patient’s
health had he or she been subject to an alternative
treatment?” Answering this question requires random
assignment of each patient to different alternative
treatments as in RCTs, which is missing in observa-
tional studies. Because treatment are not randomly
assigned, treated and control subjects are not compa-
rable before  treatment,  so  differencing  outcomes
may reﬂect these pretreatment differences rather than
effects of the treatment. Pretreatment in observed and
accurately measured covariates constitute an 
 
overt
bias
 
, such bias is visible in the data at hand and can be
removed by adjustments.
Matching is a frequently employed method to
remove overt bias and estimate the treatment effect
using observational data. One way to match focuses
directly on risk factors that are correlated with both
the outcome and the choice of treatment. For example,
suppose sex is the only important risk factor. Suppose
that we observe a treatment group that consists of 30
men and 70 women and a control group that consists
of 50 men and 50 women. We cannot estimate the
treatment effect based on the overall average difference
between these two groups because of the sex imbal-
ance. Nevertheless, we could match the men in the
treatment group to the men in the control group and
likewise the women. We could then estimate the over-
all effect as a weighted average of: 1) the average effect
for men (mean treatment cost—mean control cost for
men); and 2) the average effect for women (mean treat-
ment cost—mean control cost for women). The male/
female weight could be 30/70, 50/50, or 40/60,
depending on whether one wishes to estimate the treat-
ment savings for the treated group, the control group,
or the total population. But when it is necessary to
account for many factors, direct matching on all of the
risk factors becomes unwieldy and inefﬁcient. An alter-
native is matching on the propensity score.
Propensity score matching employs a predicted
probability of group membership (e.g., treatment vs.
control group) based on observed predictors such as
pretreatment demographic, socioeconomic and clinical
characteristics usually obtained from logistic regres-
sion to create a counterfactual group. Although logis-
tic regression is the most commonly used technique, it
is also possible to use probit, semiparametric, or non-
parametric regressions to estimate the probability of
group membership [9]. According to this technique,
the only information required is the consistent proba-
bility estimate, which is strictly between zero and one
for all covariate outcomes [10]. In this respect, linear
probability modeling is not a good choice because it is
possible to ﬁnd out-of-range predicted values for these
models.
Researchers should not ignore the important statis-
tical properties and limitations of logistic regression
models. It is the general tendency to keep the control
data set as large as possible to increase the likelihood
of ﬁnding better matches for the treatment group. It
has been shown, however, that logistic regression can
sharply underestimate the probability of rare events
 Comparison of Types of Propensity Score Matching
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[11]. Therefore, the rule of thumb is to choose a con-
trol data set at most nine times as large as the treat-
ment group, so that the overall percentage of the
treatment group is not below 10%. Established criteria
for logistic model development have been recom-
mended in recent literature [12–14].
Selection of covariates is another important step
before matching. The causality relationship among the
covariates, outcomes, and treatment variables should
be derived from theoretical relationships and a sound
knowledge of previous research [15,16]. Variables
should only be excluded from analysis if there is con-
sensus in clinicians that causality fails. To avoid omit-
ted variable bias (omitting relevant variable in our
model), we should include all variables that affect both
treatment assignment and the outcome variables.
Omitted variable bias yields inaccurate propensity
scores. Because including variables only weakly related
to treatment assignment usually reduces bias more
than it increases variance when using matching, under
most conditions these variables should be included
[17,18]. Adding an interaction term should be care-
fully considered and should be done so if it is sup-
ported both clinically and statistically. It has been
showed that adding an inappropriate interaction term
could alter the estimated propensity score, possibly
introducing bias to the estimate [14]. Furthermore, to
avoid post-treatment bias and overmatching, we
should exclude variables affected by the treatment var-
iable. The literature discusses several statistical strate-
gies for the selection of variables [19,20].
Researchers should also consider estimation power.
The Hosmer–Lemeshow [21] test is useful for detect-
ing the classiﬁcation power of the logistic regression.
The test suggests regrouping the data according to
predicted probabilities (propensity scores, in this case)
and then creating equal-size groups. The insigniﬁcant
value of the test is needed for precise classiﬁcation.
The area under the receive operator curve (ROC)
value is another way to detect classiﬁcation power. The
ROC curve is a graph of sensitivity versus one minus
speciﬁcity as the cutoff varies. The greater the predic-
tive power, the more bowed the curve. Therefore, the
area under the curve (C-statistics) can be used to deter-
mine the predictive power of logistic regression. To
classify group membership correctly, c-statistics should
be greater than 0.80. Poorly ﬁt model do not create
balance between the treatment and control groups, this
could lead to biased estimates [22].
One ﬁnal point to consider before propensity score
matching is identifying the substantial overlaps
between the treatment and comparison groups. Every
exclusion/inclusion criteria applied to the treatment
sample should also be applied to the control sample
[23].
Weitzen et al. [24] reviewed 47 studies searching
MEDLINE and Science Citation to identify observa-
tional studies in 2001 that addressed clinical questions
using propensity score methods. Of the 47 articles
reviewed, 24 (51%) were not provided information
about what method was used to select variables, 30
(64%) were unclear about whether interaction terms
were incorporated into propensity score, and 39
(83%) were not even considered goodness of ﬁt of the
propensity score and only 18 (38%) studies reports
area under ROC curve. What is more concerning was
that nearly half (22 out of 47) of the studies included
no information regarding whether the propensity score
created the balance between exposure groups on the
characteristics considered in the propensity model.
 
Types of Propensity Score Matching
 
After researchers have estimated the propensity score,
they must select a matching technique. There are ﬁve
key approaches to matching treatment and control
groups, each of which is described below.
 
Stratiﬁed Matching
 
In this method, the range of variation of the propensity
score is divided into intervals such that within each
interval, treated and control units have, on average,
the same propensity score [25]. Differences in outcome
measures between the treatment and control group in
each interval are then calculated. The average treat-
ment effect is thus obtained as an average of outcome
measure differences per block, weighted by the distri-
bution of treated units across the blocks. It has been
shown that ﬁve classes are often sufﬁcient to remove
95% of bias with all covariates [25].
 
Nearest Neighbor and 2 to 1 Matching
 
This method randomly orders the treatment and con-
trol patients, then selects the ﬁrst treatment and ﬁnds
one (two for 2 to 1 matching) control with the closest
propensity score [26]. The nearest neighbor technique
faces the risk of imprecise matches if the closest neigh-
bor is numerically distant.
 
Radius Matching
 
With radius matching, each treated unit is matched
only with the control unit whose propensity score falls
in a predeﬁned neighborhood of the propensity score
of the treated unit [27]. The beneﬁt of this approach is
that it uses only the number of comparison units avail-
able within a predeﬁned radius, thereby allowing for
use of extra units when good matches are available and
fewer units when they are not. One possible drawback
is the difﬁculty of knowing a priori what radius is
reasonable.
 
Kernel Matching
 
All treated units are matched with a weighted average
of all controls, with weights inversely proportional to
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the distance between the propensity scores of the
treated and control groups. Because all control units
contribute to the weights, lower variance is achieved.
Nevertheless, two decisions need to be made: the type
of kernel function and the bandwidth parameter. The
former appears to be unimportant [27].
 
Mahalanobis Metric Matching
 
This method randomly orders subjects and then calcu-
lates the distance between ﬁrst treated subjects and all
controls, where the distance 
 
d(i,j)
 
 
 
=
 
 
 
(u–v)
 
T
 
C
 
−
 
1
 
(u–v)
 
where 
 
u
 
 and 
 
v
 
 are the values of matching variables
(including propensity score) and 
 
C
 
 is the sample cov-
ariance matrix of matching variables from the full set
of control subjects [28].
Each of the described types can be used with
replacement (in which control patients are put back
into the pool for further possible matching) or without
replacement. To improve the quality of matching, cal-
iper can be used. The caliper method deﬁnes a com-
mon support region (suggested one-fourth of standard
error of estimated propensity score) and discards
observations whose values are outside of the range
deﬁned by caliper.
Different types bootstrapping methods can be easily
applied using standard commercial software pro-
grams. STATA and SAS ﬁles are available online
[29,30].
 
Comparing Different Types of Propensity 
Score Matching
 
The fact that several types of propensity score match-
ing exist immediately raises the question of choice:
Which one is most appropriate? Surprisingly enough,
however, the literature does not offer guidelines for
making this choice.
Matching estimators compare only exact matches
asymptotically and therefore provide the same
answers. In a ﬁnite sample, however, the speciﬁc pro-
pensity score matching technique selected makes a
difference. None of the proposed propensity score
matching techniques in the literature is a priori supe-
rior to the others.
The general tendency in the literature is to choose
matching with replacement when the control data set
is small. Matching with replacement involves a trade-
off between bias and variance (Table 1). With
replacement, the average quality of matching
increases; thus, the bias decreases but the variance
increases.
If the control data set is large and evenly distrib-
uted, 2 to 1 matching seems reasonable. Thus, reduced
variance, resulting from the use of more information to
construct the counterfactual for each participant, is
traded for increased bias because of a poorer quality
match, on average.
Kernel, Mahalanobis, and radius matching work
better with large, asymmetrically distributed control
data sets. The stratiﬁcation method is especially useful
if we suspect unobservable effects in the matching.
Because stratiﬁcation clusters similar observations, the
effects of unobservables are assumed to diminish.
We propose the following set of guidelines for
selecting the most appropriate application:
C1. Calculate two sample 
 
t
 
-statistics for continuous
variables and chi-square tests for categorical var-
iables, between the mean of the treatment group
for each explanatory variable and the mean of the
control group for each explanatory variable.
C2. Calculate the mean difference as a percentage of
the average standard deviation: 100(
 
X
 
T
 
 
 
−
 
 
 
X
 
C
 
)/
 
1
 
/
 
2
 
(
 
S
 
XT
 
 
 
+
 
 
 
S
 
XC
 
), where 
 
X
 
T
 
 and 
 
X
 
C
 
 are a set of covari-
ates, and 
 
S
 
XT
 
, 
 
S
 
XC
 
 are the standard deviation of
these covariates in the treatment and control
groups, respectively.
C3. Calculate the percent reduction bias in the means
of the explanatory variables after matching (
 
A
 
) and 
before matching (
 
I
 
): ,
where 
 
X
 
IT
 
 and 
 
X
 
IC
 
 are the mean of a covariate in
the treatment and control group, respectively,
before matching 
 
X
 
AT
 
 and 
 
X
 
AC
 
 is the mean of a cov-
ariate in the treatment and control group, respec-
tively, after matching,
C4. Use the Kalmogorov–Smirnov [31] test to com-
pare the treatment and control density estimates
for explanatory variables.
C5. Use the Kalmogorov–Smirnov test to compare the
density estimates of the propensity scores of con-
trol units with those of the treated units.
The main purpose of a matching procedure is to
reduce selection bias by increasing the balance between
the treatment and control groups. In this respect, one
would like to see insigniﬁcant differences or larger 
 
P
 
-
values (criterion 1); low mean differences as a percent-
age of the average standard deviation (criterion 2);
100% reduction bias in the means of explanatory var-
iables (criterion 3); and insigniﬁcant differences when
x x x x
x x
AT AC IT IC
IT IC
-( ) - -( )
-
¥100
 
Table 1
 
Trade-offs in terms of bias and efﬁciency
 
Types of matching algorithm Bias Variance
NN Matching
2 to 1 matching/1 to 1 matching (
 
+
 
)/(–) (–)/(
 
+
 
)
With/without caliper (–)/(
 
+
 
) (
 
+
 
)/(–)
MM matching
With/without caliper (–)/(
 
+
 
) (
 
+
 
)/(–)
Bandwidth choice of KM
Small/large (–)/(
 
+
 
) (
 
+
 
)/(–)
NN matching/radius matching (–)/(
 
+
 
) (
 
+
 
)/(–)
KM or MM matching/NN matching (
 
+
 
)/(–) (
 
+
 
)/(–)
 
KM, kernel matching; MM, Mahalanobis matching; NN, nearest neighbor; (
 
+
 
),
increase; (–), decrease.
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comparing the density estimates of the treatment and
control groups (criterion 4 and criterion 5). Therefore,
the best matching algorithm for the data is the one
which satisﬁes all ﬁve criteria.
 
Data Sources and Construction of Variables
 
To illustrate the implications of these techniques, Mar-
ketScan data were used to examine the cost of illness
for asthma patients. Details of the patient selection cri-
teria are provided in Crown et al. [32]. Brieﬂy, Mar-
ketScan contains detailed descriptions of inpatient,
outpatient medical, and outpatient prescription drug
services for approximately 13 million persons in 2005
that were covered by corporate-sponsored health-care
plans. Patients with evidence of asthma were selected
from the intersection of the medical claims and
encounter records, enrollment ﬁles, and pharmaceuti-
cal data ﬁles. Individuals meeting at least one of the
following criteria were deemed to show evidence of
asthma:
• At least two outpatient claims with primary or
secondary diagnoses of asthma.
• At least one emergency room claim with primary
diagnosis of asthma, and a drug transaction for an
asthma medication 90 days before or 7 days after
the emergency room claim.
• At least one inpatient claim with a primary diag-
nosis of asthma.
• A secondary diagnosis of asthma and a primary
diagnosis of respiratory infection in an outpatient
or inpatient claim.
• At least one drug transaction for a(n) anti-
inﬂammatory agent, oral antileukotrienes, long-
acting  bronchodilators,  or  inhaled  or  oral
short-acting beta-agonists.
• Patients with a diagnosis of chronic obstructive
pulmonary disease (COPD) and having one or
more diagnoses or procedure codes indicating
pregnancy or delivery, or who were not continu-
ously enrolled for 24 months, were excluded from
our study group.
The sociodemographic characteristics included the
age of the household, percentage of the patients who
were female and geographic region (northeast, north
central, south, west, and “other” region). Charlson
index scores (CCI) were generated to capture the level
and burden of comorbidity. Point of service plans and
other plan types, including health maintenance organ-
izations and preferred provider organizations, were
included. The analytic ﬁle contains patients with fee-
for-service (FFS) health plans and those with partially
or fully capitated plans. Data on costs were not avail-
able for the capitated plans, however. Therefore, the
value of patients’ service utilization under the capi-
tated plan was priced and imputed using average pay-
ments from the MarketScan FFS inpatient and
outpatient services by region, year, and procedure.
 
Results
 
The objective of this study is to estimate the cost of
illness for asthma patients. Therefore we deﬁned the
treatment group as the patients with evidence of
asthma, and the control group as the patients without
evidence of asthma.
Table 2 shows that before matching, treatment and
control groups were similar with respect to sex and
plan type, but quite different in terms of age, region,
and CCI. Chi-square tests were used for proportions
and 
 
t
 
-tests were used for continuous variables.
Estimation of propensity scores with logit is pre-
sented in Table 3. As expected, sex and plan type were
not signiﬁcant. Several interaction terms were added
into the models. 
 
F
 
-tests on these interaction terms yield
insigniﬁcant results. Age was also entered with spines,
but there was no evidence of signiﬁcant changes in
results. Overall coefﬁcients were signiﬁcant
(
 
P
 
 
 
<
 
 0.000), and pseudo-
 
R
 
2
 
 revealed that the equation
explains 24.3% of variation in the choice. The area
under the ROC curve was calculated as 0.863. These
values indicate the potential beneﬁt of matching the
sample according to propensity scores.
 
Table 2
 
Descriptive table for treatment and control cohorts
 
Variables
Treatment
(N 
 
=
 
 1184)
Control 
(N 
 
=
 
 3169) Differences
Mean Mean
 
P
 
-values
Age 28.026 31.368 0.000
Female 0.506 0.514 0.646
Male 0.494 0.486 0.646
Northeast 0.218 0.234 0.248
North central 0.253 0.213 0.005
South 0.378 0.331 0.004
West 0.110 0.099 0.314
Other region 0.042 0.122 0.000
CCI 0.999 0.159 0.000
Point of service 0.720 0.721 0.908
Other plan type 0.280 0.279 0.908
 
Table 3
 
Estimation of propensity score with logit
 
Variables Coefﬁcients SE
 
P
 
-values
95% conﬁdence
interval
North central 0.301 0.115 0.009 0.077 to 0.526
South 0.184 0.104 0.077
 
−
 
0.020 to 0.387
West 0.280 0.146 0.055
 
−
 
0.006 to 0.567
Other region
 
−
 
1.428 0.289 0.000
 
−
 
1.995 to 
 
−
 
0.861
CCI 1.887 0.069 0.000 1.751 to 2.023
Age
 
−
 
0.033 0.003 0.000
 
−
 
0.039 to 
 
−
 
0.028
Female
 
−
 
0.030 0.081 0.716
 
−
 
0.189 to 0.130
Point of service
 
−
 
0.043 0.090 0.635
 
−
 
0.220 to 0.134
Constant
 
−
 
0.934 0.127 0.000
 
−
 
1.183 to 
 
−
 
0.686
N 4353
Prob 
 
>
 
 
 
χ
 
2
 
0.000
Pseudo-
 
R
 
2
 
0.243
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We applied the following types of propensity
matching: nearest neighbor (M1), 2 to 1 (M2), Maha-
lanobis (M3), Mahalanobis with caliper (M4), radius
(M5), kernel (M6), and stratiﬁed matching (M7). All
balance-checking criteria are presented in Table 3.
One can immediately observe that criterion 1,
which is the method most commonly used in applica-
tions, can be misleading. Although all regional differ-
ences between treatment and control groups were
signiﬁcant according to nearest neighbor and 2 to 1
matching (M1 and M2), an overall density comparison
revealed insigniﬁcant differences.
Radius, kernel, and stratiﬁed matching (M5, M6,
and M7) seemed to render results similar to nearest
neighbor and 2 to 1 matching. Statistics were consist-
ent across the tables.
Mahalanobis matching (M3 and M4) was distinc-
tively better than the others. Especially with caliper
(M4), calculated as 0.06 (one-fourth of the standard
error or estimated propensity score), Mahalanobis
matching was able to match our treatment and control
groups in all salient aspects. In terms of criterion 1, all
of the variables were insigniﬁcant. The mean difference
as a percentage of the average standard deviation was
less than 5% for age and northeast region, and virtu-
ally nothing for the others. For most variables, Maha-
lanobis matching with caliper was able to decrease the
bias 100%, and densities for each variable were statis-
tically equal. Moreover, M4 was the only technique
that produced propensity scores of control units and
treated units with insigniﬁcant differences.
After we selected the most appropriate matching
technique, we estimated total health-care expenditures
in the treatment and control cohorts. We did this in
two ways: 1) by examining the differences in means of
expenditure between the treatment and matched con-
trol units; and 2) by running a regression, in which the
independent variables are the treatment indicator and
the same variables used in propensity score estimation,
and by estimating the marginal effects of the treatment
indicator. Following Manning and Mullahy [33], we
used a generalized linear model with a log link and
gamma family. Table 4 presents these results.
Mahalanobis with caliper matching estimated the
treatment effect as $4463. This is $2590 less than the
unmatched difference and $2423 more than the
amount obtained by the wrongly chosen method of
stratiﬁed matching. The difference is both practically
and statistically signiﬁcant.
Using the selected matching technique, the regres-
sion-based difference between the matched control and
treatment groups was $4456. By running a regression
after matching, we were able to decrease the standard
errors almost threefold. Note that correct matching
technique provides the estimate that is closest to the
regression counterpart ($4463 
 
−
 
 $4456 
 
=
 
 $7).
Another advantage of running regressions is that
regression allows for convergence of the values. For
example, the unmatched difference after regression
was $4247, which represents a difference of only $209
from the correctly chosen propensity score technique.
Similarly, in the case of stratiﬁed matching, the differ-
ence would be only $702 after regression, rather than
$2423, which is precisely the difference without
regression.
 
Discussion
 
Many researchers are accustomed to data from
planned experiments where patients are assigned ran-
domly to treatment or control group status. In many
other instances, though, researchers often have to rely
on nonexperimental, observational data to estimate
the effects of treatments on outcomes, such as total
health-care costs, which are difﬁcult or impossible to
estimate in the artiﬁcial setting of a clinical trial. In this
latter environment, we observe costs for treated and
untreated patients, but the two groups are often unbal-
anced with respect to important risk factors that may
inﬂuence the outcomes of interest. As a result of this
imbalance, two forms of bias can arise when compar-
isons are made between the treatment and control
groups: overt bias, which is measurable, and 
 
hidden
bias
 
, which is unobservable. Overt bias can be
removed with properly applied propensity score
matching, whereas hidden bias must be addressed by
other methods.
It is worth noting this distinction between overt and
hidden bias, when considering the merits of propensity
score matching in comparison to the merits of a
 
Table 4 Estimated total health-care expenditures ($)
Matching type Treatment Control Difference SE
Regression-based 
Difference SE
Unmatched 10,398 3,345 7,053 742 4,247 489
M1: Nearest neighbor 10,398 7,377 3,021 1,275 3,969 1,135
M2: 2 to 1 10,398 7,364 3,034 978 5,157 1,232
M3: Mahalanobis 10,398 6,892 3,506 2,281 4,823 1,205
M4: Mahalanobis with caliber 11,104 6,641 4,463 3,252 4,456 994
M5: Radius 10,398 7,786 2,612 1,278 4,601 659
M6: Kernel 10,398 7,942 2,456 2,281 4,823 1,205
M7: Stratiﬁed 10,398 8,358 2,040 2,564 3,754 1,009
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randomized trial. When both are feasible, randomiza-
tion would be preferred, because propensity score
matching would remove only observed differences
(overt bias) between treatment and control groups,
whereas RCTs, when properly conducted, would
remove both observed and unobserved differences.
The performance of different matching estimators
varies case by case and depends largely on the data
structure at hand. Researchers should not introduce
any additional bias, such as choice bias resulting from
failure to check balancing criteria. Empirical work
shows the value of multivariate analysis in this respect.
Supported by multivariate analysis, the average treat-
ment estimates  converge  on  each  other,  regardless
of the propensity score type chosen. Occasionally,
researchers are unwilling to lose any observations from
the treatment group. In these cases, the present
research proposes using a propensity score matching
that retains the largest treatment group, while support-
ing the use of multivariate analysis after matching.
The heterogeneity of a real-life patient population
and a lack of standardized analysis in observational
studies may make clinicians suspicious of the results of
propensity score matching. Presentation of Tables 3
and 5 to clinicians is thus clearly valuable. Table 3
shows the process whereby we eliminate the heteroge-
neity of a real-life population, and Table 5 demon-
strates that the right type of propensity score matching
yields an answer similar to that of multivariate
analysis.
Two limitations should be noted. First, if two
groups do not have substantial overlap, then substan-
tial error may be introduced. New methods are under
development to account for limited overlap in the
Table 5 Balance-checking criteria
Variables M1 M2 M3 M4 M5 M6 M7
C1: T-test or chi-square test P-values
Age 0.000 0.000 0.001 0.709 0.000 0.000 0.000
Female 0.267 0.868 0.870 0.999 0.233 0.376 0.255
Northeast 0.005 0.003 0.514 0.482 0.002 0.000 0.006
North central 0.000 0.000 0.962 0.999 0.000 0.000 0.000
South 0.000 0.000 0.966 0.999 0.003 0.000 0.000
West 0.000 0.000 0.948 0.999 0.610 0.024 0.450
Other region 0.000 0.000 0.999 0.999 0.000 0.000 0.000
CCI 0.000 0.000 0.255 0.999 0.000 0.000 0.000
Point of service 0.407 0.937 0.891 0.999 0.455 0.689 0.515
Other plan type 0.407 0.937 0.891 0.999 0.455 0.689 0.515
C2: The mean difference as a percentage of the average standard deviation
Age 57.900 55.500 13.500 2.200 50.400 56.100 48.500
Female 4.600 0.600 0.700 0.000 4.900 3.600 4.100
Northeast 11.600 10.800 2.700 4.200 12.800 15.900 10.200
North central 20.600 17.100 0.200 0.000 18.000 19.600 16.400
South 29.000 28.700 0.200 0.000 12.200 20.100 25.700
West 17.400 15.100 0.300 0.000 2.100 9.300 3.500
Other region 43.400 42.300 0.000 0.000 34.400 38.000 30.400
CCI 26.700 25.700 4.700 0.000 19.300 25.000 20.700
Point of service 3.400 0.300 0.600 0.000 4.900 1.600 2.800
Other plan type 3.400 0.300 0.600 0.000 4.900 1.600 2.800
C3: Percent reduction bias in means of explanatory variables
Age 182.700 172.200 37.900 123.400 143.000 174.400 151.600
Female 191.800 137.800 143.200 100.000 212.900 132.400 150.800
Northeast 201.000 178.100 166.300 54.600 233.100 316.100 250.400
North central 109.800 75.900 102.100 100.000 84.800 99.500 88.500
South 187.000 184.300 98.200 100.000 25.400 103.400 154.500
West 676.800 595.500 108.100 100.000 163.800 394.100 389.500
Other region 149.900 141.500 100.000 100.000 83.300 108.900 135.500
CCI 130.700 129.400 105.100 100.000 123.000 128.900 120.500
Point of service 759.600 28.400 43.300 100.000 212.900 316.200 268.600
Other plan type 759.600 28.400 43.300 100.000 212.900 316.200 268.600
C4: Comparison of treatment and control density estimates
Age 0.000 0.000 0.000 0.156 0.000 0.000 0.000
Female 0.999 0.999 0.999 0.830 0.999 0.990 0.890
Northeast 0.999 0.999 0.999 0.999 0.972 0.972 0.950
North central 0.787 0.374 0.999 0.999 0.129 0.129 0.850
South 0.997 0.999 0.256 0.999 0.050 0.050 0.080
West 0.969 0.677 0.616 0.927 0.999 0.999 0.490
Other region 0.761 0.953 0.999 0.999 0.123 0.123 0.350
CCI 0.000 0.000 0.000 0.153 0.000 0.000 0.000
Point of service 0.999 0.999 0.989 0.864 0.999 0.999 0.988
Other plan type 0.999 0.999 0.989 0.864 0.999 0.999 0.988
C5: Comparison of the density estimates of the propensity scores of control units with those of the treated units
Propensity scores 0.000 0.000 0.001 0.192 0.000 0.000 0.000
CCI, Charlson index scores.
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estimation of the average treatment effect [33]. Sec-
ond, matching may not eliminate hidden bias. Sup-
pose, for example, that we match people according
to certain observable factors and then attribute any
resulting difference in outcomes to differences in
treatment. It is quite possible that the outcomes of
patients with the same observable characteristics can
vary widely because of some unobservable factor,
such as physician- or practice-prescribing patterns.
The bounding approach under propensity score
matching is proposed to address this issue [4]. Rosen-
baum assumes a latent unobservable factor and
answers such questions as how strongly an unmeas-
ured variable must inﬂuence a selection process in
order for it to undermine the implication of matching
analysis. The other solution would be to use tech-
niques different from that of propensity score match-
ing, such as instrumental variable estimation or
difference in difference estimation. But these estima-
tors are confounded by their own limitations.
Conclusion
The merits of using propensity score matching tech-
nique have become increasingly recognized over the
years as its application has grown. Nevertheless, dif-
ferent propensity score matching techniques may
produce different results in ﬁnite samples. Sensitivity
analysis of the matching techniques is especially
important because none of the proposed methods in
the literature is a priori superior to the others. This
article has discussed the seven common types of pro-
pensity score matching techniques and provides guide-
lines to choose among them.
A case study, involving the analysis of US health
expenditure data, has been presented to highlight how
different types of propensity score matching tech-
niques have substantial effect on the magnitude of
treatment effect. Regression analysis is used to support
the argument.
The discussion in this article does not provide
detailed or rigorous treatment of the theory that
underlies the matching technique. In recent years, sev-
eral articles on propensity score matching techniques,
with various level of sophistication, have been pub-
lished. Curious readers are encouraged to consult these
articles for a more detailed analysis [3,4,10,15,17–
20,25–28,34,35].
This article beneﬁted greatly from insightful comments
offered by Ron J. Ozminkowski, Kathy Schulman, Tami
Mark, Robert Houchens, and four anonymous referees. The
opinions expressed in this article are the author’s and do
not necessarily reﬂect the opinions of their afﬁliated
organizations.
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